International Pancreatic Surgery Outcomes Study - PancreasGroup.Org
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04652271|
Recruitment Status : Not yet recruiting
First Posted : December 3, 2020
Last Update Posted : September 16, 2021
|Condition or disease||Intervention/treatment|
|Pancreatic Neoplasms Pancreatitis||Procedure: Pancreatic surgery|
The PancreasGroup.org team is conducting a "snapshot" clinical study investigating the outcomes of pancreatic surgery worldwide. This "collaborative" model for snapshot clinical studies is a well-established approach for assessing current practice in a short period of time.
There will be 3 months of prospective enrolment and 3 months follow up within a 12-month frame. The study will provide highly valuable data on outcomes after pancreatic surgery.
The investigators are aiming at providing a verified record of true morbidity and mortality in consecutive unselected patients. This way the investigators will help identify relevant, modifiable predicting factors for outcome after pancreatic surgery.
|Study Type :||Observational|
|Estimated Enrollment :||3500 participants|
|Official Title:||PancreasGroup.Org - International Pancreatic Surgery Outcomes Study|
|Estimated Study Start Date :||September 2021|
|Estimated Primary Completion Date :||March 31, 2022|
|Estimated Study Completion Date :||March 31, 2022|
Patients undergoing pancreatic surgery
Patients undergoing any type of pancreatic surgery.
Procedure: Pancreatic surgery
Open, laparoscopic or robotic surgery of the pancreas
- Mortality [ Time Frame: 90 days postoperatively ]Postoperative death
- Morbidity [ Time Frame: 90 days postoperatively ]Postoperative complication rates classified according to Clavien-Dindo
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04652271
|Contact: Guiseppe K Fusai, MD, MSfirstname.lastname@example.org|
|Contact: Dimitri A Raptis, MD, MSc, PhDemail@example.com|
|Study Chair:||Guiseppe K Fusai, MD, MS||Royal Free Hospital London, UK|
|Study Chair:||Cristina Ferrone, MD||Massachusetts General Hospital, Boston, USA|
|Principal Investigator:||Dimitri A Raptis, MD, MSc, PhD||Royal Free Hospital London, UK|